Market Overview

US Stock Futures Up Ahead Of Earnings

US Stock Futures Up Ahead Of Earnings
Related VZ
American Tower Corp To Continue Global Focus
Verizon's Results Suggest 'Cord Cutting Is Actually Starting To Accelerate'
Capitalize On Canada's Wireless Oligopoly Now with BCE's 5.2% Dividend Yield (GuruFocus)
Related GE
Orix Says It Is Buying 17 Aircraft From GE Aviation Unit, ~$750M Value
S&P 500 Index Futures Trading Lower In Volatile Session
Let Them Eat Spreadsheets (Seeking Alpha)

Pre-open movers

US stock futures rose in early pre-market trade, ahead of earnings from major companies. Futures for the Dow Jones Industrial Average surged 18 points to 15,314.00, while the Standard & Poor's 500 index futures rose 1.70 points to 1,729.50. Futures for the Nasdaq 100 index gained 14 points to 3,315.00.

A Peek Into Global Markets

European markets were higher today, with the Spanish Ibex Index rising 0.38%, London's FTSE 100 index gaining 0.33% and STOXX Europe 600 Index rising 0.44%. German DAX 30 index rose 0.17% and French CAC 40 Index surged 0.49%.

Asian markets ended mostly higher today. Japan's Nikkei Stock Average declined 0.17%, China's Shanghai Composite rose 0.24% and Hong Kong's Hang Seng Index surged 1.06%. Australia's ASX/S&P500 surged 0.74% and India's Sensex jumped 2.29%. China's gross domestic product rose 7.8% in the third quarter, versus a 7.5% growth in the second quarter. The country's industrial output rose 10.2% in September from a 10.4% growth in August, while retail sales grew 13.3% versus a 13.4% growth increase in the earlier month.

Broker Recommendation

Analysts at Deutsche Bank upgraded Verizon Communications (NYSE: VZ) from “hold” to “buy.” The target price for Verizon Communications has been raised from $49 to $56.

Verizon's shares gained 1.02% to $49.40 in pre-market trading.

Breaking news

  • General Electric Co (NYSE: GE) reported an 8.6% drop in its third-quarter net profit. GE's quarterly profit declined to $3.2 billion, or $0.31 per share, down from $3.5 billion, or $0.33 per share, in the year-ago period. To read the full news, click here.
  • pSivida (NASDAQ: PSDV) today announced that its licensee Alimera Sciences, Inc. has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and Drug Administration (FDA). To read the full news, click here.
  • Schlumberger (NYSE: SLB) reported a 20% rise in its third-quarter profit. Schlumberger's quarterly profit surged to $1.72 billion, or $1.29 per share, from $1.42 billion, or $1.07 per share, in the year-ago period. To read the full news, click here.
  • Pier 1 Imports (NYSE: PIR) today announced its Board of Directors has authorized a new $200 million share repurchase program. To read the full news, click here.

Posted-In: Deutsche Bank US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (GE + PIR)

Get Benzinga's Newsletters